Numerous possibilities to expand India-Japan cooperation: Diplomat
"We've had active discussions, where lots of issues were discussed and there were many good analyses, ideas, and suggestions. Also, we have difficulties and challenges as well. But I realized that there are many potentials and possibilities to expand our cooperation," he said while speaking at the Indo-Japan International Conference organised by the Centre for Public Policy Research here.
Chennai-based Pharma company recalls eye drops from US market after 55 adverse cases
The US government agency Centre for Disease Control and Prevention said there were 55 adverse cases including eye infections, permanent loss of vision and one death due to a blood stream infection. Five people turned completely blind on using the eye drops.Global Health pharma's product lubricant eye drops distributed by Ezricare, LLC and Delsam Pharma in the US was being investigated by the Centre for Disease Control and Prevention. However, the eye drops are not sold in India.
Despite lower sales volume, vehicle makers to post higher profit, revenue
According to the report, the vehicle makers are expected to post de-growth of revenue and net profit on a sequential basis due to the reduction in wholesales sales in December 2022 post-festive season due to the normalization of channel inventories. On the demand scenario, Axis Securities said the commercial vehicles growth would continue with the government infrastructure push and replacement demand.
A new feather in AdaniConneX's cap: Chennai 1 Data Centre is now Live!
With an integrated terrestrial fibre and global submarine cable connectivity, Chennai has emerged as a major data centre hub in the APAC region. AdaniConneX's 'Chennai 1' data centre with a total capacity of 33MW (IT load) is strategically positioned to support rising demand in the region.